SARS-CoV-2 as a protective factor for cardiovascular mortality?

被引：0
|
作者：
Dutheil, Frederic [1 ]
Trousselard, Marion [2 ]
Navel, Valentin [3 ]
机构：
[1] Univ Clermont Auvergne, CHU Clermont Ferrand, Univ Hosp Clermont Ferrand, CNRS,LaPSCo,Physiol & Psychosocial Stress,Prevent, F-63000 Clermont Ferrand, France
[2] French Armed Forces Biomed Res Inst IRBA, Neurophysiol Stress Neurosci & Operat Constraint, F-91000 Bretigny Sur Orge, France
[3] Univ Clermont Auvergne, CHU Clermont Ferrand, Univ Hosp Clermont Ferrand,Ophthalmol, CNRS,INSERM,GReD,Translat Approach Epithelial Inj, F-63000 Clermont Ferrand, France
来源：
ATHEROSCLEROSIS | 2020年 / 304卷
关键词：
AIR-POLLUTION; STATEMENT; EXPOSURE; DISEASE; EVENTS; LONG;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：64 / 65
页数：2
相关论文
共 50 条
  • [41] What are protective antibody responses to pandemic SARS-CoV-2?
    Henderson, Jeffrey P.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2020, 130 (12): : 6232 - 6234
  • [42] Efficiency of Respiratory Protective Equipment in the SARS-CoV-2 Pandemic
    K. I. Lukanina
    A. K. Budyka
    I. E. Rebrov
    K. G. Antipova
    S. N. Malakhov
    A. D. Shepelev
    T. E. Grigoriev
    V. A. Yamshchikov
    S. N. Chvalun
    [J]. Nanobiotechnology Reports, 2021, 16 : 69 - 88
  • [43] A COMPARISON OF CARDIOVASCULAR OUTCOMES AMONG SARS-COV-2 POSITIVE PATIENTS, SARS-COV-2 NEGATIVE PATIENTS, AND A HISTORICAL COHORT
    May, Heidi Thomas
    Knight, Stacey
    Horne, Benjamin Davies
    Bair, Tami L.
    Anderson, Jeffrey L.
    Le, Viet T.
    Muhlestein, J. Brent
    Knowlton, Kirk U.
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 1842 - 1842
  • [44] The Acid Ceramidase Is a SARS-CoV-2 Host Factor
    Geiger, Nina
    Kersting, Louise
    Schlegel, Jan
    Stelz, Linda
    Faehr, Sofie
    Diesendorf, Viktoria
    Roll, Valeria
    Sostmann, Marie
    Koenig, Eva-Maria
    Reinhard, Sebastian
    Brenner, Daniela
    Schneider-Schaulies, Sibylle
    Sauer, Markus
    Seibel, Jurgen
    Bodem, Jochen
    [J]. CELLS, 2022, 11 (16)
  • [45] SARS-CoV-2
    Steinbauer, M.
    Boeckler, D.
    [J]. GEFASSCHIRURGIE, 2020, 25 (06): : 387 - 388
  • [46] SARS-CoV-2 Influence on Pregnant Women with Cardiovascular Diseases
    Barbu, Roxana Mihaela
    Pohaci-Antonesei, Luiza
    Stana, Bogdan
    Cojocaru, Cristian
    Pohaci-Antonesei, Catalin
    Cojocaru, Elena
    Gavrilescu, Cristina Maria
    Oprisa, Cristina
    [J]. 2021 INTERNATIONAL CONFERENCE ON E-HEALTH AND BIOENGINEERING (EHB 2021), 9TH EDITION, 2021,
  • [47] SARS-CoV-2
    Wallet, France
    [J]. ENVIRONNEMENT RISQUES & SANTE, 2021, 20 (03): : 330 - 333
  • [48] Cardiovascular implications of SARS-CoV-2 infection: A literature review
    Garcia-Saavedra, Mario B.
    Rosales-Gutierrez, Renzo R.
    Valverde, Esmeralda
    Chumbes-Aguirre, Maryuri
    Alvarado, Ricardo
    Polo, Robert
    Azanero, Ruben
    Chavez, Carlos
    [J]. MEDWAVE, 2020, 20 (07):
  • [49] Cardiovascular dysautonomia in postacute sequelae of SARS-CoV-2 infection
    Stahlberg, Marcus
    Mahdi, Ali
    Johansson, Madeleine
    Fedorowski, Artur
    Olshansky, Brian
    [J]. JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2024, 35 (03) : 608 - 617
  • [50] GEOGRAPHICAL INEQUALITIES IN CORONAVIRUS (SARS-COV-2) MORTALITY IN EUROPE
    Elmer, D.
    Endrei, D.
    Csakvari, T.
    Nemeth, N.
    Horvath, L.
    Danku, N.
    Kives, Z.
    Boncz, I
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S129 - S129
12345